We are live on ! Find out more
FHTX icon

Foghorn Therapeutics

90 hedge funds and large institutions have $148M invested in Foghorn Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

3% more funds holding

Funds holding: 8790 (+3)

0.28% more ownership

Funds ownership: 72.41%72.69% (+0.28%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

22% less capital invested

Capital invested by funds: $190M → $148M (-$42.4M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
90
Holders Change
+3
Holders Change %
+3.45%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
26
Reduced
30
Closed
5
Calls
Puts
$3K
Net Calls
-$3K
Net Calls Change
-$7K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$58.9K -$184K -40,405 -71%
Los Angeles Capital Management
52
Los Angeles Capital Management
California
$57.9K +$105 +23 +0.1%
Mirae Asset Global ETFs Holdings
53
Mirae Asset Global ETFs Holdings
Hong Kong
$55.1K +$2.85K +624 +4%
AWA
54
Alta Wealth Advisors
Massachusetts
$54.9K
D.E. Shaw & Co
55
D.E. Shaw & Co
New York
$54.3K -$390K -85,492 -85%
SPA
56
Sherbrooke Park Advisers
New York
$47.7K -$11.6K -2,542 -16%
CF
57
Corebridge Financial
Texas
$45.2K -$839 -184 -1%
SG Americas Securities
58
SG Americas Securities
New York
$44K +$3.28K +720 +6%
CUAMC
59
China Universal Asset Management Company
China
$40.7K -$2.89K -633 -5%
FT
60
Fiduciary Trust
Massachusetts
$39.7K
Lazard Asset Management
61
Lazard Asset Management
New York
$35K -$3.53K -774 -7%
Acadian Asset Management
62
Acadian Asset Management
Massachusetts
$34K -$120K -26,289 -73%
EPAM
63
Evelyn Partners Asset Management
$25.9K
PFSRSONJ
64
Police & Firemen's Retirement System of New Jersey
New Jersey
$18.5K
Nisa Investment Advisors
65
Nisa Investment Advisors
Missouri
$18.5K -$137 -30 -0.6%
TRCT
66
Tower Research Capital (TRC)
New York
$14.2K +$8.14K +1,786 +85%
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
$11.6K -$44.6K -9,780 -76%
Legal & General Group
68
Legal & General Group
United Kingdom
$9.88K
Carson Wealth (CWM LLC)
69
Carson Wealth (CWM LLC)
Nebraska
$7K +$8.09K +1,774 +9,856%
New York State Common Retirement Fund
70
New York State Common Retirement Fund
New York
$6.83K
California State Teachers Retirement System (CalSTRS)
71
California State Teachers Retirement System (CalSTRS)
California
$6.68K
Mirae Asset Global Investments
72
Mirae Asset Global Investments
South Korea
$6.55K +$36 +8 +0.4%
Simplex Trading
73
Simplex Trading
Illinois
$6K +$5.02K +1,102 +162%
AIP
74
Ameritas Investment Partners
Nebraska
$5.6K
WT
75
Washington Trust
Rhode Island
$5.47K

FHTX Hedge Fund Activity: Q1 2025 in Review

90 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q1 2025, worth a combined $148M — down 22% from $190M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new FHTX positions and 5 closed out — a net gain of 3 holders — while 26 added to existing stakes and 30 trimmed.

The largest buyer was Raymond James Financial, adding an estimated $861K. The largest seller was Fidelity Investments, cutting an estimated $460K.

  • 90 institutional investors held Foghorn Therapeutics (FHTX) as of Q1 2025, up from 87 in Q4 2024.
  • Funds reported $148M of Foghorn Therapeutics stock for Q1 2025, down 22% quarter-over-quarter.
  • 8 funds opened new Foghorn Therapeutics positions in Q1 2025 and 5 closed out, a net change of +3 holders.
  • The largest Foghorn Therapeutics buyer in Q1 2025 was Raymond James Financial, an estimated $861K added.
  • The largest Foghorn Therapeutics seller in Q1 2025 was Fidelity Investments, an estimated $460K sold.

Based on aggregated 13F filings for Q1 2025.